These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37276599)

  • 81. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial.
    Adam L; Moutzouri E; Baumgartner C; Loewe AL; Feller M; M'Rabet-Bensalah K; Schwab N; Hossmann S; Schneider C; Jegerlehner S; Floriani C; Limacher A; Jungo KT; Huibers CJA; Streit S; Schwenkglenks M; Spruit M; Van Dorland A; Donzé J; Kearney PM; Jüni P; Aujesky D; Jansen P; Boland B; Dalleur O; Byrne S; Knol W; Spinewine A; O'Mahony D; Trelle S; Rodondi N
    BMJ Open; 2019 Jun; 9(6):e026769. PubMed ID: 31164366
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pharmacogenetics in clinical dermatology.
    Ameen M; Smith CH; Barker JN
    Br J Dermatol; 2002 Jan; 146(1):2-6. PubMed ID: 11841360
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pharmacogenetic Markers of Drug Efficacy and Toxicity.
    Yip VL; Hawcutt DB; Pirmohamed M
    Clin Pharmacol Ther; 2015 Jul; 98(1):61-70. PubMed ID: 25870137
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?
    Solomon HV; Cates KW; Li KJ
    Psychiatry Res; 2019 Jan; 271():604-613. PubMed ID: 30554109
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Optimising psychotropic medication prescribing to reduce adverse drug events.
    Strydom A; Melville C
    J Intellect Disabil Res; 2019 May; 63(5):369-371. PubMed ID: 30993818
    [No Abstract]   [Full Text] [Related]  

  • 86. Personalized pharmacogenomics: predicting efficacy and adverse drug reactions.
    Pirmohamed M
    Annu Rev Genomics Hum Genet; 2014; 15():349-70. PubMed ID: 24898040
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Clinical association between pharmacogenomics and adverse drug reactions.
    Zhou ZW; Chen XW; Sneed KB; Yang YX; Zhang X; He ZX; Chow K; Yang T; Duan W; Zhou SF
    Drugs; 2015 Apr; 75(6):589-631. PubMed ID: 25895462
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Impact of CYP2C19 Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic-Pharmacokinetic Prospective Multicenter Study.
    Blanco-Dorado S; Maroñas O; Latorre-Pellicer A; Rodríguez Jato MT; López-Vizcaíno A; Gómez Márquez A; Bardán García B; Belles Medall D; Barbeito Castiñeiras G; Pérez Del Molino Bernal ML; Campos-Toimil M; Otero Espinar F; Blanco Hortas A; Durán Piñeiro G; Zarra Ferro I; Carracedo Á; Lamas MJ; Fernández-Ferreiro A
    Pharmacotherapy; 2020 Jan; 40(1):17-25. PubMed ID: 31782536
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Whole-genome sequencing in pharmacogenetics.
    Urban TJ
    Pharmacogenomics; 2013 Mar; 14(4):345-8. PubMed ID: 23438878
    [No Abstract]   [Full Text] [Related]  

  • 90. Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients.
    Dong OM; Li A; Suzuki O; Oni-Orisan A; Gonzalez R; Stouffer GA; Lee CR; Wiltshire T
    Pharmacogenomics; 2018 Jun; 19(9):771-782. PubMed ID: 29793377
    [TBL] [Abstract][Full Text] [Related]  

  • 91. General considerations for integrating pharmacogenomics into mainstream medical practice.
    Patrinos GP
    Hum Genomics; 2010 Aug; 4(6):371-4. PubMed ID: 20846925
    [No Abstract]   [Full Text] [Related]  

  • 92. Implementation of inpatient models of pharmacogenetics programs.
    Cavallari LH; Lee CR; Duarte JD; Nutescu EA; Weitzel KW; Stouffer GA; Johnson JA
    Am J Health Syst Pharm; 2016 Dec; 73(23):1944-1954. PubMed ID: 27864202
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pharmacogenomic Primer for the Pediatrician-What Is Really Important?
    Manzi S
    Pediatr Ann; 2018 May; 47(5):e217-e219. PubMed ID: 29750289
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Do regulatory safety warnings on medicines miss the mark?
    Mintzes B
    Drug Ther Bull; 2024 Mar; 62(4):50. PubMed ID: 38458656
    [No Abstract]   [Full Text] [Related]  

  • 95. [Pharmacogenetics in primary care: a tool to prevent adverse reactions to drugs].
    Capilla Díaz S; Gamero de Luna EJ
    Semergen; 2024 Jun; 50(6):102273. PubMed ID: 38861920
    [No Abstract]   [Full Text] [Related]  

  • 96. Using pharmacogenetics to understand adverse drug reactions in children.
    Shaw K; Amstutz U; Carleton BC
    Paediatr Child Health; 2011 Nov; 16(9):537-8. PubMed ID: 23115490
    [No Abstract]   [Full Text] [Related]  

  • 97. Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study.
    Agulló L; Aguado I; Muriel J; Margarit C; Gómez A; Escorial M; Sánchez A; Fernández A; Peiró AM
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445931
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Noncoding RNAs and Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Cardiac Arrhythmic Brugada Syndrome.
    Theisen B; Holtz A; Rajagopalan V
    Cells; 2023 Oct; 12(19):. PubMed ID: 37830612
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Genotype-guided drug prescribing vs. usual care reduced clinically relevant adverse drug reactions at 12 wk.
    Holbrook AM
    Ann Intern Med; 2023 Jun; 176(6):JC70. PubMed ID: 37276599
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
    Swen JJ; van der Wouden CH; Manson LE; Abdullah-Koolmees H; Blagec K; Blagus T; Böhringer S; Cambon-Thomsen A; Cecchin E; Cheung KC; Deneer VH; Dupui M; Ingelman-Sundberg M; Jonsson S; Joefield-Roka C; Just KS; Karlsson MO; Konta L; Koopmann R; Kriek M; Lehr T; Mitropoulou C; Rial-Sebbag E; Rollinson V; Roncato R; Samwald M; Schaeffeler E; Skokou M; Schwab M; Steinberger D; Stingl JC; Tremmel R; Turner RM; van Rhenen MH; Dávila Fajardo CL; Dolžan V; Patrinos GP; Pirmohamed M; Sunder-Plassmann G; Toffoli G; Guchelaar HJ;
    Lancet; 2023 Feb; 401(10374):347-356. PubMed ID: 36739136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.